GSA Capital Partners LLP cut its holdings in Cardiovascular Systems Inc (NASDAQ:CSII) by 14.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 15,970 shares of the medical device company’s stock after selling 2,730 shares during the quarter. GSA Capital Partners LLP’s holdings in Cardiovascular Systems were worth $450,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of CSII. New York State Common Retirement Fund grew its position in shares of Cardiovascular Systems by 346.8% in the 2nd quarter. New York State Common Retirement Fund now owns 443,304 shares of the medical device company’s stock valued at $14,288,000 after purchasing an additional 344,082 shares during the period. Point72 Asset Management L.P. grew its position in shares of Cardiovascular Systems by 132.7% in the 3rd quarter. Point72 Asset Management L.P. now owns 469,978 shares of the medical device company’s stock valued at $13,230,000 after purchasing an additional 267,988 shares during the period. Fred Alger Management Inc. acquired a new position in shares of Cardiovascular Systems in the 2nd quarter valued at approximately $7,327,000. Vanguard Group Inc. grew its position in shares of Cardiovascular Systems by 12.6% in the 2nd quarter. Vanguard Group Inc. now owns 1,864,604 shares of the medical device company’s stock valued at $60,096,000 after purchasing an additional 208,248 shares during the period. Finally, Gabelli Funds LLC grew its position in shares of Cardiovascular Systems by 223.1% in the 3rd quarter. Gabelli Funds LLC now owns 218,500 shares of the medical device company’s stock valued at $6,151,000 after purchasing an additional 150,880 shares during the period. Institutional investors and hedge funds own 74.86% of the company’s stock.
Several equities research analysts have commented on the company. Needham & Company LLC cut Cardiovascular Systems from a “buy” rating to a “hold” rating and cut their target price for the company from $33.11 to $23.00 in a research note on Friday, December 15th. William Blair restated a “market perform” rating on shares of Cardiovascular Systems in a research note on Thursday, December 21st. Raymond James Financial restated a “hold” rating on shares of Cardiovascular Systems in a research note on Monday, December 4th. Zacks Investment Research upgraded Cardiovascular Systems from a “sell” rating to a “hold” rating in a research note on Monday, November 13th. Finally, BidaskClub upgraded Cardiovascular Systems from a “strong sell” rating to a “sell” rating in a research note on Thursday. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $31.50.
Cardiovascular Systems (NASDAQ:CSII) last released its earnings results on Wednesday, October 25th. The medical device company reported ($0.06) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.02. The firm had revenue of $49.70 million for the quarter, compared to analysts’ expectations of $51.00 million. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The business’s quarterly revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.06) EPS. equities research analysts expect that Cardiovascular Systems Inc will post -0.03 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This article was posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/3126369/cardiovascular-systems-inc-csii-shares-sold-by-gsa-capital-partners-llp.html.
Cardiovascular Systems Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems Inc (NASDAQ:CSII).
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.